NSC | Compound | Enrichment | Correlation |
---|---|---|---|
NSC 606497 | Camptothecin Derivative | 0.00567322425730621 | 0.35447288 |
NSC 643836 | Null | 0.00567322425730621 | 0.45327898 |
NSC 687793 | Null | 0.00567322425730621 | 0.44857709 |
NSC 693207 | Null | 0.00567322425730621 | 0.31381823 |
NSC 694001 | 2-Butenedioic acid, (E)-, 2-[3-[[[4-(acetyloxy)butyl]- 1H-1,2,3-triazol-4-yl]methyl]-1,2,3,4-tetrahydro-5-methyl-2,4-dioxo-1-pyrimidinyl]-, diethyl ester | 0.00567322425730621 | 0.30678561 |
NSC 694620 | Null | 0.00567322425730621 | 0.18898193 |
NSC 700363 | Liposomal Annamycin | 0.00567322425730621 | 0.44067364 |
NSC 700851 | Null | 0.00567322425730621 | 0.46173643 |
NSC 704640 | Null | 0.00567322425730621 | 0.56417159 |
NSC 727729 | 1, 1'[Pentane-1,5-diyl)dioxy]bis(11as)-2-fluoro-7-methoxy-1,2,3 ,11a-tetrahydro-5H-pyrrolo[2,1-c][1,4]benzodiazepin-5-one | 0.00567322425730621 | 0.40529857 |